Navigation Links
Fat molecule ceramide may factor in muscle loss in older adults
Date:10/31/2012

As men and women age, increasing quantities of fat tissue inevitably take up residence in skeletal muscle. A small study of older and younger men conducted at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University suggests that a build-up of a fat molecule known as ceramide might play a leading role in muscle deterioration in older adults. The results of the study were published online this month by the Journal of Applied Physiology, a publication of the American Physiological Society.

The study enrolled ten 10 men in their mid-seventies to nine men in their early twenties. None of the men carried excess weight or had chronic health problems and none had exercised in six months. Ceramide was measured in a muscle biopsy taken at baseline. The participants performed a single bout of exercise (three sets of ten repetitions of knee extensions and leg presses) followed by two muscle biopsies which the authors used to examine how the exercise impacted muscle growth response.

"There is a known relationship between elevated ceramide levels and unhealthy muscle in obese adults, but to the best of our knowledge, this had not been studied in healthy weight, older adults," said Donato Rivas, Ph.D., the study's first author and a scientist in the Nutrition, Exercise Physiology and Sarcopenia Laboratory at the USDA HNRCA at Tufts University. "Our analysis of the muscle biopsies showed an accumulation of two types of ceramide molecules containing saturated fatty acids that were 156% and 30% higher in the older men. Furthermore, having higher accumulation of one of these saturated fatty acid types was associated with having less leg muscle mass in both younger and older men."

"Although it is well known that fat tissue replaces some of our muscle tissue as we grow older, we are seeking to understand whether some fat molecules are more damaging to muscle than others," said Roger A. Fielding, Ph.D., senior author and director of the Nutrition, Exercise Physiology and Sarcopenia Laboratory. "We suspect that the increased storage of ceramide we saw in the older men, exacerbated by the presence of saturated fat, has a part in weakening the anabolic signaling that responds to resistance exercises and helps with the assembly of new muscle."

Learning more about ceramide activity through larger, long-term interventional trials involving older and younger men and women may identify a role in dietary or therapeutic drug interventions for sarcopenia, an age-related condition of muscle loss and function.

"The deterioration of muscle is compounded by a loss of muscle strength, which really begins to decline around age 50 and appears to be a factor in the visible decrease in mobility people exhibit around age 80," added Fielding, who is also a professor at the Friedman School of Nutrition Science and Policy at Tufts University and at Tufts University School of Medicine. "Previous research done at Tufts and other institutions suggests that even with limited exercise older adults can maintain and build some new muscle. Until there is enough research to develop specific exercise and dietary interventions, staying as physically active as deemed safe by your health care provider can only benefit aging muscle."


'/>"/>

Contact: Andrea Grossman
617-636-3728
Tufts University, Health Sciences Campus
Source:Eurekalert

Related medicine news :

1. New developments reveal a molecule with a promising function in terms of cancer treatment.
2. Measuring molecules with the naked eye
3. Molecule shows effectiveness against drug-resistant myeloma
4. Molecule found that inhibits recovery from stroke
5. Cleveland Clinic researchers discover molecule that may prevent atherosclerosis
6. Mayo Clinic: Molecule thought cancer foe actually helps thyroid tumors grow
7. Inhibitors of shuttle molecule show promise in acute leukemia
8. Researchers identify a life-and-death molecule on chronic leukemia cells
9. Prions in the brain eliminated by homing molecules
10. Molecule movements that make us think
11. Smoking and hyperactivity share common genetic risk factor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... While it’s often important to take certain ... inventor from Austin, Texas, has identified a solution. , She developed a prototype for ... lighting. As such, it eliminates the need to turn on a light when taking ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with clinical ... the primary prevention of cardiovascular diseases during the 15th Annual Women’s Health ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... ... , ... Talented host, actor Rob Lowe, is introducing a ... episode of "Success Files," which is an award-winning educational program broadcasted on PBS ... in-depth with passion and integrity. , Sciatica occurs when the sciatic nerve in ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance ... management, will showcase a range of technology and learning solutions at the 68th ... and Expo to be held October 14–18, 2017 at the Mandalay Bay Resort ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017 Halo Labs announces the ... analysis system called the HORIZON at MIBio 2017 in ... subvisible and visible particulate matter in biopharmaceutical samples with unprecedented speed ... of the novel technique Backgrounded Membrane Imaging. ... The HORIZON subvisible particle analysis system ...
(Date:9/27/2017)... for their devotion to personalized service, SMP Pharmacy Solutions announces ... the South Florida Business Journal,s 50 Fastest-Growing Companies, and listed ... national specialty pharmacy has found its niche.  To that end, ... honored by SFBJ as the 2017 Power Leader in Health ... his award in October, Bardisa said of the three achievements, ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: